Guidelines for the Pharmacotherapy of osteoporosis
NOFSA (National Osteoporosis Federation of South Africa ) recommendations on the choice of a pharmacological agent in the treatment of osteoporosis:
a. We acknowledge the fact that, given the heterogeneity of the osteoporosis syndrome and the lack of significant head-to-head comparative studies, no ideal drug scenario for management can be recommended.
b. Drug therapy must be individualised, taking due cognisance of the disease profile (particularly the severity of bone loss and skeletal sites involved), the patient profile (age, general health, concomitant disease, clinical setting), and the available resources and personal preferences.
The Hows and Whys of Osteoporosis Medications
CLASS AND DRUG | BRAND NAME | FORM | FREQUENCY | GENDER |
---|---|---|---|---|
Antiresorptive Agents | ||||
Bisphosphonates | ||||
Alendronate | Fosamax®, Fosamax Plus D™ | Oral (tablet, solution) | Daily/Weekly | Women & Men |
Alendronate | Binosto® | Oral (effervescent tablet) | Weekly | Women & Men |
Ibandronate | Boniva® | Oral (tablet) | Monthly | Women |
Ibandronate | Boniva® | Intravenous (IV) injection | Every 3 months | Women |
Risedronate | Actonel® | Oral (tablet) | Daily/Weekly/Twice Monthly/Monthly | Women & Men |
Risedronate | Atelvia™ | Oral (tablet) | Weekly | Women |
Zoledronic Acid | Reclast® | Intravenous (IV) infusion | One Time per Year/Once every two years | Women & Men |
RANK ligand (RANKL) inhibitor | ||||
Denosumab | Prolia™ | Injection | Every 6 Months | Women & Men |
Calcitonin | ||||
Calcitonin | Fortical®, Miacalcin® | Nasal spray | Daily | Women |
Calcitonin | Miacalcin® | Injection | Varies | Women |
Estrogen* (Hormone Therapy) | ||||
Estrogen | Multiple Brands | Oral (tablet) | Daily | Women |
Estrogen | Multiple Brands | Transdermal (skin patch) | Twice Weekly/Weekly | Women |
| ||||
Raloxifene | Evista® | Oral (tablet) | Daily | Women |
Tissue Specific Estrogen Complex (TSEC) | ||||
Estrogen/Bazodoxifene | Duavee® | Oral (tablet) | Daily | Women |
Anabolic Agents | ||||
Sclerostin Inhibitor | ||||
Romosozumab-aqqg | Evenity | Injection | 2 injections once monthly for 12 months | Women |
Parathyroid Hormone (PTH) Analog | ||||
Teriparatide | Forteo® | Injection | Daily | Women & Men |
Parathyroid Hormone-Related Protein (PTHrp) Analog | ||||
Abaloparatide | Tymlos | Injection | Daily | Women |
*Estrogen is also available in other preparations including a vaginal ring, cream, by injection and as an oral tablet taken sublingually (under the tongue). The vaginal preparations do not provide significant bone protection. |
Osteoporosis Medication and Medication Guidelines (nof.org)
Reference:
JEMDSA 145 2017; 22(1) (Supplement 1)